Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 45, 2013 - Issue 5
Submit an article Journal homepage
632
Views
40
CrossRef citations to date
0
Altmetric
Original Articles

Kratom Abuse in Ramathibodi Poison Center, Thailand: A Five-Year Experience

Satariya Trakulsrichai M.D Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
,
Achara Tongpo M.Sc Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand
,
Charuwan Sriapha M.Sc Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand
,
Sunun Wongvisawakorn M.Sc Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand
,
Panee Rittilert M.Sc Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand
,
Sming Kaojarern M.D Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand
&
Winai Wananukul M.D Ramathibodi Poison Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand
 show all
Pages 404-408 | Published online: 18 Nov 2013

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Darshan Singh, Suresh Narayanan, Oliver Grundmann, Edward W. Boyer & Balasingam Vicknasingam. (2020) The Use of Benzodiazepines among Kratom (Mitragyna Speciosa Korth.) Users. Journal of Psychoactive Drugs 52:1, pages 86-92.
Read now
Sara Post, Henry A. Spiller, Thitphalak Chounthirath & Gary A. Smith. (2019) Kratom exposures reported to United States poison control centers: 2011–2017. Clinical Toxicology 57:10, pages 847-854.
Read now
Cornel N. Stanciu, Samantha A. Gnanasegaram, Saeed Ahmed & Thomas Penders. (2019) Kratom Withdrawal: A Systematic Review with Case Series. Journal of Psychoactive Drugs 51:1, pages 12-18.
Read now
Satariya Trakulsrichai, Korbtham Sathirakul, Saranya Auparakkitanon, Jatupon Krongvorakul, Jetjamnong Sueajai, Nantida Noumjad, Chonlaphat Sukasem & Winai Wananukul. (2015) Pharmacokinetics of mitragynine in man. Drug Design, Development and Therapy 9, pages 2421-2429.
Read now
Darshan Singh, Christian P. Müller, Balasingam K. Vicknasingam & Sharif M. Mansor. (2015) Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia. Journal of Psychoactive Drugs 47:2, pages 125-131.
Read now

Articles from other publishers (35)

Rima Atria Japarin, Norsyifa Harun, Zurina Hassan & Christian P. Müller. (2023) The dopamine D1 receptor antagonist SCH-23390 blocks the acquisition, but not expression of mitragynine-induced conditioned place preference in rats. Behavioural Brain Research 453, pages 114638.
Crossref
Courtney Jarka & Kelsey Gregoire. (2023) Precipitated withdrawal with kratom use following naltrexone administration. Mental Health Clinician 13:3, pages 155-158.
Crossref
Xiaotong Li, Patrick Ndungu, Sanya B. Taneja, Maryann R. Chapin, Susan B. Egbert, Krishi Akenapalli, Mary F. Paine, Sandra L. Kane‐Gill & Richard D. Boyce. (2023) An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021 . Clinical and Translational Science 16:6, pages 1002-1011.
Crossref
Oliver Grundmann, Robert G. Hendrickson & Michael I. Greenberg. (2023) Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month 69:6, pages 101442.
Crossref
Corneliu N. Stanciu, Samantha A. Gnanasegaram, Gerald L. RaderIIIIII, Abhisheak Sharma & Christopher R. McCurdy. (2023) What Is the Kratom Overdose Risk? A Systematic Literature Review. Current Addiction Reports 10:1, pages 9-28.
Crossref
Noah Reich, Grazia Salvo, Dennis Leong, Victoria Wan & Tom Kosatsky. (2022) Kratom exposures managed by the British Columbia poison centre, 2012–2019: a descriptive analysis. CMAJ Open 10:3, pages E755-E761.
Crossref
Yotsapon Thewjitcharoen, Sirinate Krittiyawong, Soontaree Nakasatien & Thep Himathongkam. (2022) Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report. Clinical Medicine Insights: Case Reports 15, pages 117954762211328.
Crossref
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, Jenny L. Wilkerson, Christopher R. McCurdy & Lance R. McMahon. 2022. Behavioral Pharmacology of Drug Abuse: Current Status. Behavioral Pharmacology of Drug Abuse: Current Status 35 76 .
Ismail Nurul Iman, Nur Aimi Zawami Ahmad, Nurul Aiman Mohd Yusof, Ummi Nasrah Talib, Anwar Norazit, Jaya Kumar, Muhammad Zulfadli Mehat, Zurina Hassan, Christian P. Müller & Mustapha Muzaimi. (2021) Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism. Frontiers in Pharmacology 12.
Crossref
Sanihah Abdul Halim, Jen Hou Low, Yong Chuan Chee & Muhamad Ridzuan Alias. (2021) Seizures among young adults consuming kratom beverages in Malaysia: A case series. Epilepsy & Behavior 121, pages 108057.
Crossref
Erin Coonan & William Tatum. (2021) Kratom: The safe legal high?. Epilepsy & Behavior 117, pages 107882.
Crossref
Devin J. BurkeSarah G. MahonskiAnne C. Van Cott. (2021) Breakthrough Seizure Associated With Kratom Use in Patients With Epilepsy. Neurology Clinical Practice 11:1, pages 78-84.
Crossref
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, Francesco Paolo Busardò & Jeremy Carlier. (2020) Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. Pharmaceuticals 13:10, pages 309.
Crossref
Rebecca S. Williams & Dmitriy Nikitin. (2020) The internet market for Kratom, an opioid alternative and variably legal recreational drug. International Journal of Drug Policy 78, pages 102715.
Crossref
Jonathan Schimmel & Richard C. Dart. (2020) Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review. Drugs 80:3, pages 263-283.
Crossref
Donna M Papsun, Ayako Chan-Hosokawa, Laura Friederich, Justin Brower, Kristopher Graf & Barry Logan. (2019) The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine. Journal of Analytical Toxicology 43:8, pages 615-629.
Crossref
John M Corkery, Peter Streete, Hugh Claridge, Christine Goodair, Duccio Papanti, Laura Orsolini, Fabrizio Schifano, Kanav Sikka, Sophie Körber & Amy Hendricks. (2019) Characteristics of deaths associated with kratom use. Journal of Psychopharmacology 33:9, pages 1102-1123.
Crossref
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, Oliver Grundmann, Jack E. Henningfield, Andrew C. Kruegel, Lance R. McMahon, Christopher R. McCurdy, Marc T. Swogger, Charles A. Veltri & Darshan Singh. (2019) Kratom policy: The challenge of balancing therapeutic potential with public safety. International Journal of Drug Policy 70, pages 70-77.
Crossref
Hafez Mohammad Ammar Abdullah, Iqra Haq & Randall Lamfers. (2019) Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this ’legal high' substance more dangerous than initially thought ?. BMJ Case Reports 12:7, pages e229778.
Crossref
L. Davidson, M. Rawat, S. Stojanovski & P. Chandrasekharan. (2019) Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to ‘kratom’. Journal of Neonatal-Perinatal Medicine 12:1, pages 109-112.
Crossref
Summon Chomchai, Jariya Phuditshinnapatra, Pattaraporn Mekavuthikul & Chulathida Chomchai. (2019) Effects of unconventional recreational drug use in pregnancy. Seminars in Fetal and Neonatal Medicine 24:2, pages 142-148.
Crossref
Sirasa Ruangritchankul & Sahaphume Srisuma. (2019) The pattern of substance abuse in Thai elderly: Ramathibodi Poison Center. SAGE Open Medicine 7, pages 205031211987351.
Crossref
Whitney B. Eldridge, Cherie Foster & Lance Wyble. (2018) Neonatal Abstinence Syndrome Due to Maternal Kratom Use. Pediatrics 142:6.
Crossref
Souparno Mitra & Sanya Virani. (2020) Kratom and Neonatal Abstinence Syndrome: A Nascent Association. Journal of Neonatology 32:4, pages 98-105.
Crossref
Kyungeun Bae, Nam ji Kwon & Eunyoung Han. (2018) A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia. Forensic Science International 292, pages 45-49.
Crossref
Marcela C. Smid, Jasmin E. Charles, Adam J. Gordon & Tricia E. Wright. (2018) Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy. Obstetrics & Gynecology 132:4, pages 926-928.
Crossref
Marc T. Swogger & Zach Walsh. (2018) Kratom use and mental health: A systematic review. Drug and Alcohol Dependence 183, pages 134-140.
Crossref
Lauren LaBryer, Rohan Sharma, Kaustubh Suresh Chaudhari, Mitali Talsania & Robert Hal Scofield. (2018) Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report. Journal of Investigative Medicine High Impact Case Reports 6, pages 232470961876502.
Crossref
William O. Tatum, Tasneem F. Hasan, Erin E. Coonan & Christopher P. Smelick. (2018) Recurrent seizures from chronic kratom use, an atypical herbal opioid. Epilepsy & Behavior Case Reports 10, pages 18-20.
Crossref
Kirk L. Cumpston, Michael Carter & Brandon K. Wills. (2018) Clinical outcomes after Kratom exposures: A poison center case series. The American Journal of Emergency Medicine 36:1, pages 166-168.
Crossref
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, Ornella Corazza, Rita Santacroce & Andres Roman-Urrestarazu. (2017) Changing trends in the use of kratom ( Mitragyna speciosa ) in Southeast Asia . Human Psychopharmacology: Clinical and Experimental 32:3, pages e2582.
Crossref
Walter C. Prozialeck. (2016) Update on the Pharmacology and Legal Status of Kratom. Journal of Osteopathic Medicine 116:12, pages 802-809.
Crossref
Darshan Singh, Suresh Narayanan & Balasingam Vicknasingam. (2016) Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin 126, pages 41-46.
Crossref
Mehruba AnwarRoyal LawJosh Schier. (2016) Notes from the Field : Kratom ( Mitragyna speciosa ) Exposures Reported to Poison Centers — United States, 2010–2015 . MMWR. Morbidity and Mortality Weekly Report 65:29, pages 748-749.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.